CD83 IS A NEW POTENTIAL BIOMARKER AND THERAPEUTIC TARGET FOR HODGKIN LYMPHOMA

EHA Library, Ziduo Li, 215860

HETEROZYGOUS CONSTITUTIVE CALR DEL52 KNOCK-IN MICE SHOW A TRANSPLANTABLE ET-PHENOTYPE WHILE THE HOMOZYGOUS STATE IS LETHAL DUE TO A HEART DEFECT

EHA Library, Thomas Balligand, 215875

ANTI-SLAMF7 ANTIBODY SUPPRESSES FIBROCYTE DIFFERENTIATION AS A POTENT THERAPEUTIC AGENT FOR MYELOFIBROSIS

EHA Library, Takaaki Maekawa, 215874

PROGNOSTIC SIGNIFICANCE OF MAGNETIC RESONANCE IMAGING BEFORE AND AFTER UPFRONT AUTOLOGOUS TRANSPLANTATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA – A SUBGROUP ANALYSIS FROM THE GMMG MM5 PHASE III TRIAL

EHA Library, Maximilian Merz, 215873

GENOMIC CHARACTERIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS IN MULTIPLE MYELOMA REVEALS DISTINCT PATTERNS OF DISEASE EVOLUTION

EHA Library, Aino-Maija Leppä, 215872

NOVEL KINASE INHIBITORS AFURESERTIB AND PIM447 ARE ACTIVE IN A PREDICTIVE MYELOMA IN VIVO MODEL, AND A CRISPR GENOME-WIDE SCREENING APPROACH IDENTIFIES BIOMARKERS DETERMINING SUSCEPTIBILITY

EHA Library, Niamh Keane, 215871

PEPTIDE STIMULATION OF PD-L1 SPECIFIC T CELLS NATURALLY OCCURING IN MYELOMA PATIENTS AUGMENT THE ADCC ACTIVITY OF DARATUMUMAB

EHA Library, Nicolai Jørgensen, 215870

ADAR1-MEDIATED-A-TO-I-EDITING IS BIOLOGICALLY AND CLINICALLY RELEVANT IN MULTIPLE MYELOMA

EHA Library, Phaik Ju Teoh, 215869

EXPRESSION OF P53 ISOFORMS AT MRNA LEVEL IN MULTIPLE MYELOMA: IMPLICATIONS FOR CLINICAL OUTCOME

EHA Library, Elizabeta A. Rojas, 215868

THE EVALUATION OF OXIDATIVE STRESS AND IRON METABOLISM MARKERS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Mihnea-Alexandru Găman, 215867

CLINICAL OUTCOMES OF PATIENTS WITH MDS/MPN OVERLAP SYNDROMES

EHA Library, Caroline MCNAMARA, 215866

PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND MULTILINEAGE DYSPLASIA WITH OR WITHOUT RING SIDEROBLASTS.

EHA Library, Abhishek Mangaonkar, 215865

SOMATIC MUTATIONS AS MARKERS OF OUTCOME AFTER AZACITIDINE TREATMENT FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTION (HSCT) IN HIGHER-RISK (HR) MDS AND LOW-BLAST COUNT ACUTE MYELOID LEUKEMIA (LBC-AML)

EHA Library, Giulia Falconi, 215864

TISSUE IRON OVERLOAD ASSESSMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Kira Lukina, 215863

IRON OVERLOAD IN RARE HEREDITARY HEMOLYTIC ANEMIA

EHA Library, Stephanie van Straaten, 215862

AUTOLOGOUS STEM CELL TRANSPLANTATION MAY CURE FOLLICULAR LYMPHOMA PATIENTS WITH EARLY THERAPY FAILURE WHO REACH COMPLETE RESPONSE AFTER RESCUE TREATMENT IRRESPECTIVE OF PREVIOUS RITUXIAMB EXPOSURE.

EHA Library, Ana Jiménez Ubieto, 215861

PATIENT-DERIVED INDUCED PLURIPOTENT STEM CELLS REVEALED CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE 2 AS A POTENTIAL THERAPEUTIC TARGET OF MYELOFIBROSIS

EHA Library, Masashi Miyauchi, 215876

THE IN VIVO EFFECT OF CHEMOTHERAPY AND CXCR4 ANTAGONISM ON AML AND T-ALL CELL MIGRATION IN THE BONE MARROW.

EHA Library, Delfim Duarte, 215859

AGE-RELATED CLONAL HEMATOPOIESIS (ARCH) IN CENTENARIANS AND CARDIOVASCULAR DISEASE PATIENTS: A SURVIVAL BIAS HYPOTHESIS

EHA Library, Luca Bertamini, 215858

TISSUE PLASMINOGEN ACTIVATOR GENE POLYMORPHISM AND RECURRENCE OF VENOUS THROMBOEMBOLISM IN YOUNG PATIENTS FROM THE NORTH-WEST REGION OF RUSSIA

EHA Library, Anna Chechulova, 215889

ANTICOAGULATION IN THE OBESE - A PROSPECTIVE REGISTRY

EHA Library, Georgia McCaughan, 215888

A HIGH PRE-TREATMENT BONE MARROW CD34+/CD38- CELL BURDEN IN PATIENTS WITH MYELODYSPLASTIC SYNDROME IS A PROGNOSTIC FACTOR FOR DISEASE PROGRESSION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Madlen Jentzsch, 215887

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT IN THE OUTPATIENT SETTING: A SINGLE CENTER EXPERIENCE OF 924 CONSECUTIVE TRANSPLANTS

EHA Library, Salwa Saadeh, 215886

DETERMINANTS AND CLINICAL SIGNIFICANCE OF MUSCULOSKELETAL SYMPTOMS IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE

EHA Library, Ana Zelić Kerep, 215885

A QUALITATIVE ANALYSIS OF PSYCHOLOGICAL HEALTH MEASURES IN SURVIVORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA AFTER BEING TREATED WITH BFM-ALL PROTOCOLS

EHA Library, Asif Iqbal, 215884

SHORT- AND LONG-TERM ELTROMBOPAG FOR THE TREATMENT OF INHERITED THROMBOCYTOPENIAS: A PHASE 2 CLINICAL TRIAL

EHA Library, Carlo Zaninetti, 215883

PREEMPTIVE RITUXIMAB HAS A FAVORABLE BENEFIT-RISK BALANCE IN THE PREVENTION OF LONG-TERM RELAPSES IN IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Matthieu Jestin, 215882

MYC-MEDIATED DOWNREGULATION OF MIR-150 CONTRIBUTES TO THE TRANSFORMATION OF FOLLICULAR LYMPHOMA BY UPREGULATING FOXP1 LEVELS

EHA Library, Jan Devan, 215881

SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY

EHA Library, Stine Ulrik Mikkelsen, 215880

MUTATIONAL LANDSCAPE AND ITS IMPACT ON OUTCOMES IN ACCELERATED AND BLAST PHASE OF MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Caroline Mcnamara, 215879

PATIENTS WITH LOW JAK2 ALLELE BURDEN HAVE A HIGH RATE OF CO-OCCURRENT CALR MUTATIONS BEARING AN EFFECT ON DISEASE PHENOTYPE IN ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS.

EHA Library, Barbara Mora, 215878

DEVELOPMENT OF A PROGNOSTICALLY RELEVANT ‘CACHEXIA INDEX’ IN PRIMARY MYELOFIBROSIS USING SERUM ALBUMIN AND CHOLESTEROL LEVELS

EHA Library, maura nicolosi, 215877

PRECLINICAL VALIDATION OF VECABRUTINIB (SNS-062) EFFICIENCY AGAINST BTK-C481S MUTATED LYMPHOMAS

EHA Library, Camille Libre, 215841

IDENTIFICATION OF NOVEL MECHANISMS UNDERLYING FUNCTIONAL RESPONSE TO DRUG-INDUCED READTHROUGH OF HAEMOPHILIA B NONSENSE MUTATIONS

EHA Library, Mattia Ferrarese, 215842

APPLICATION OF THE ISTH BLEEDING SCORE IN HEMOPHILIA

EHA Library, NAVEENA FATIMA, 215844

LOW PROPORTION OF MYELOID DERIVED SUPPRESSOR CELL POPULATIONS IN THE PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA

EHA Library, Nikoleta Bizymi, 215845

CLINICAL SIGNIFICANCE OF PNH CLONES IN 3085 PATIENTS WITH CYTOPENIA: A LARGE SINGLE-CENTER EXPERIENCE.

EHA Library, Bruno Fattizzo, 215846

USP28 LOCALIZED IN 11Q23 REGULATES C-MYC, NOTCH1 AND FBXW7 IN CLL

EHA Library, Viola Meyer-Pannwitt, 215847

DYNAMIC REGULATION OF THE HS1/CXCR4 AXIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS

EHA Library, Luca Pavesi, 215848

EPIGENETIC DRUG SCREEN ON RITUXIMAB-RESISTANT CELLS REVEALED AN UNEXPECTED ROLE OF AURORA KINASE INHIBITORS IN CD20 EXPRESSION

EHA Library, Veronika Kozlova, 215849

B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN CLL PATIENTS TREATED WITH LENALIDOMIDE

EHA Library, Moritz Fürstenau, 215850

IMPLEMENTATION OF THE DIAGNOSTIC WORKFLOW OF HEREDITARY ANEMIAS BY USING TARGETED-NGS PANEL ANALYSIS

EHA Library, Roberta Russo, 215851

CONGENITAL ERYTHROPOIETIC PORPHYRIA AS A MIMICKER OF CHRONIC HEMOLYTIC ANEMIAS IN INFANTS

EHA Library, Yasmine El Chazli, 215852

DUAL TARGETING STRATEGY OF ACUTE MYELOID LEUKEMIA BY ENGINEERED CYTOKINE-INDUCED KILLER CELLS COEXPRESSING AN INTERLEUKIN 3 CHIMERIC ANTIGEN RECEPTOR (CAR) AND AN ANTI-CD33 COSTIMULATORY RECEPTOR

EHA Library, Vincenzo Perriello, 215853

SYNERGISTIC T CELL SIGNALING BY CD79A/CD40 COSTIMULATORY ENDODOMAIN ENHANCES CD19 CHIMERIC ANTIGEN RECEPTOR T CELL PROLIFERATION AND SURVIVAL

EHA Library, Jakrawadee Julamanee, 215854

RNAI-MEDIATED SILENCING OF ENDOGENOUS TCR ENHANCES TUMOR KILLING ACTIVITY OF TCR-ENGINEERED WT1-SPECIFIC T CELLS

EHA Library, Diana Campillo, 215855

THE STUDY OF LYMPHOCYTES SUBPOPULATIONS IN PERIPHERAL BLOOD OF PATIENTS WITH AND WITHOUT GVHD PROPHYLAXIS BY MEANS OF MULTIPOTENT MESENCHYMAL STROMAL CELLS AFTER ALLOGENEIC BMT

EHA Library, Yulia Davydova, 215856

NORADRENALINE STIMULATES MITOCHONDRIAL REALLOCATION AND HAEMATOPOIETIC MIGRATION TO THE SPLEEN

EHA Library, Adam Morfakis, 215857

RELEVANCE: PHASE III EFFICACY AND SAFETY STUDY OF LENALIDOMIDE PLUS RITUXIMAB (R2) VERSUS RITUXIMAB PLUS CHEMOTHERAPY, FOLLOWED BY RITUXIMAB, IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA

EHA Library, Franck Morschhauser, 215924

MPN CALR MUTANTS PROMOTE CELL-SURFACE LOCALIZATION OF TPOR WHICH IS OBLIGATORY FOR ONCOGENESIS: NOVEL THERAPEUTIC AVENUES AND RESCUE OF CONGENITAL THROMBOCYTOPENIA TPOR MUTANTS

EHA Library, Christian Pecquet, 215926

CHRONIC RED BLOOD CELL TRANSFUSIONS IMPAIR THE INNATE IMMUNE RESPONSE TO INFECTIOUS CUES BY SHAPING MACROPHAGES TOWARDS AN ANTI-INFLAMMATORY FUNCTIONAL PHENOTYPE.

EHA Library, Francesca Vinchi, 215928

Test

EHA Library, Romain Froger, 219400

OVERALL SURVIVAL BENEFIT OF OBINUTUZUMAB OVER RITUXIMAB WHEN COMBINED WITH CHLORAMBUCIL IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND COMORBIDITIES: FINAL SURVIVAL ANALYSIS OF THE CLL11 STUDY

EHA Library, Valentin Goede, 215923

RIBOSOMAL LESIONS PROMOTE ONCOGENIC MUTAGENESIS

EHA Library, Sergey Sulima, 215927

FIRST-IN-HUMAN CLL1-CD33 COMPOUND CAR T CELLS AS A TWO-PRONGED APPROACH FOR THE TREATMENT OF REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Fang Liu, 215925

Perspectives with CAR-T for resistant ALL and beyond

EHA Library, Sara Ghorashian, 219119

Resolving hematopoiesis by fate mapping and polylox barcoding

EHA Library, Hans-Reimer Rodewald, 219122

Designing clinical scale production of iPSC-derived platelets by a novel flow concept

EHA Library, Koji Eto, 219123

Epigenetic inhibitors in hematological malignancies

EHA Library, Brian Huntly, 219125

Inhibitors of isocitrate dehydrogenase in the treatment of acute myeloid leukemia

EHA Library, Eytan Stein, 219126

Blood transfusion in developing countries: The case of Malawi and other African countries

EHA Library, Brindon M'baya, 219128

How to test and transfuse blood products in sub-Saharan Africa

EHA Library, Jean Pierre Allain, 219129

David Grimwade Award Lecture: Precision medicine for blood cancers through knowledge banks

EHA Library, Peter Campbell, 219116

Award ceremony: Presentation Young EHA Best abstracts

EHA Library, Martina Muckenthaler, 219479

Opening Ceremony: Chair

EHA Library, Martina Muckenthaler, 219114

Award ceremony

EHA Library, Ruud Delwel, 219115

Award ceremony: Education and mentoring awards

EHA Library, Pieter Sonneveld, 219480

Opening Ceremony: Chair

EHA Library, Pieter Sonneveld, 219113

CC-122, A NOVEL CEREBLON-MODULATING AGENT, IN COMBINATION WITH OBINUTUZUMAB (GA101) IN PATIENTS WITH RELAPSED AND REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (NHL)

EHA Library, Jean-Marie Michot, 214437

A NOVEL ΒETA1-TUBULIN-BASED MEGAKARYOCYTE REPORTER SYSTEM IDENTIFIES COMPOUNDS THAT PROMOTE MEGAKARYOCYTE MATURATION AND PLATELET PRODUCTION

EHA Library, Si Jing Chen, 214600

FATIGUE AT BASELINE IS ASSOCIATED WITH GERIATRIC IMPAIRMENTS AND PREDICTS SHORTER SURVIVAL IN OLDER PATIENTS WITH A HEMATOLOGICAL MALIGNANCY

EHA Library, Reinhard Stauder, 214520

RELAPSED AML IN CHILDREN: IMPROVED OUTCOME

EHA Library, Mareike Rasche, 214441

RESURRECTING RESPONSE TO RUXOLITINIB: A PHASE I STUDY TESTING THE COMBINATION OF RUXOLITINIB AND THE PI3K DELTA INHIBITOR UMBRALISIB IN RUXOLITINIB-EXPERIENCED MYELOFIBROSIS

EHA Library, Tamara Moyo, 214514

REDUCED-INTENSITY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR DIFFUSE LARGE B-CELL LYMPHOMA: COMPARABLE OUTCOMES OF HAPLO-IDENTICAL VS. FULLY MATCHED RELATED DONORS. A CIBMTR & EBMT ANALYSIS

EHA Library, Peter Dreger, 214512

STAG2 REGULATES HEMATOPOIETIC DIFFERENTIATION AND SELF-RENEWAL

EHA Library, Yotaro Ochi, 214509

CHECKMATE 205 COHORT D: A PHASE 2 TRIAL OF NIVOLUMAB FOR NEWLY DIAGNOSED ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA

EHA Library, Radhakrishnan Ramchandren, 214507

UPDATED EFFICACY AND MRD DATA ACCORDING TO RISK-STATUS IN NEWLY DIAGNOSED MYELOMA PATIENTS TREATED WITH CARFILZOMIB PLUS LENALIDOMIDE OR CYCLOPHOSPHAMIDE: RESULTS FROM THE FORTE TRIAL

EHA Library, Francesca Gay, 214503

BB2121 ANTI-BCMA CAR T CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS FROM A MULTICENTER PHASE I STUDY

EHA Library, Jesus Berdeja, 214444

LEUKEMIA CELL-DERIVED MICROVESICLES INDUCE T CELL EXHAUSTION VIA MIRNA DELIVERY

EHA Library, Jieke Cui, 214598

RESULTS OF A PHASE 1B/2 STUDY OF ENTOSPLETINIB (GS-9973) MONOTHERAPY AND IN COMBINATION WITH INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Alison Walker, 214440

ALTERED COHESIN ACTIVITY AT DIFFERENTIATION-SPECIFIC ACTIVE CIS-REGULATORY ELEMENTS PREDICTS THE FATE OF COHESIN-PERTURBED HAEMATOPOIESIS

EHA Library, Daniel Sasca, 214595

ABNORMAL BLEEDING ASSOCIATED WITH COAGULATION ABNORMALITIES IN SYSTEMIC AMYLOIDOSIS

EHA Library, Kai Sun, 214519

TRENDS IN THE USE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE MANAGEMENT OF RELAPSED/REFRACTORY HODGKIN LYMPHOMA. A RETROSPECTIVE ANALYSIS OF THE LYMPHOMA WORKING PARTY OF THE EBMT

EHA Library, Anna Sureda, 214442

BRENTUXIMAB VEDOTIN + ESHAP (BRESHAP) FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT: HIGH COMPLETE REMISSION RATE AND LONG-TERM TIME TO TREATMENT FAILURE IN REFRACTORY/RELAPSED HODGKIN LYMPHOMA.

EHA Library, Ramon Garcia-Sanz, 214506

COMPARISON OF LONG-TERM EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B VS. HU IN POLYCYTHEMIA VERA PATIENTS AGED BELOW OR ABOVE 60 YEARS: TWO-YEAR ANALYSIS FROM THE PROUD/CONTINUATION PHASE III TRIALS

EHA Library, Heinz Gisslinger, 214443

IMPROVEMENTS IN CARDIAC BIOMARKERS ARE ASSOCIATED WITH BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS

EHA Library, Tiffany Quock, 214447

CONSOLIDATION FOLLOWED BY MAINTENANCE VS MAINTENANCE ALONE IN NEWLY DIAGNOSED, TRANSPLANT ELIGIBLE MULTIPLE MYELOMA: A RANDOMIZED PHASE 3 STUDY OF THE EUROPEAN MYELOMA NETWORK (EMN02/HO95 MM TRIAL)

EHA Library, Pieter Sonneveld, 214488

TP53 MUTATIONS, BUT NOT NOTCH2 OR KLF2 MUTATIONS, IDENTIFY PATIENTS WITH POOR PROGNOSIS IN SPLENIC MARGINAL ZONE LYMPHOMA – INTERIM ANALYSIS OF THE IELSG46 STUDY

EHA Library, Francesca Guidetti, 214485

INTERIM ANALYSIS OF THE DALIAH TRIAL - A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA-2 VS. HYDROXYUREA IN MPN PATIENTS.

EHA Library, Trine Alma Knudsen, 214492

DARATUMUMAB PLUS BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) IN ELDERLY (≥75 YEARS OF AGE) PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA INELIGIBLE FOR TRANSPLANTATION (ALCYONE)

EHA Library, Jesús San Miguel, 214502

BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY IN HIGH RISK ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA (CHL) PATIENTS: RESULTS OF PRE-SPECIFIED SUB-GROUP ANALYSES FROM THE ECHELON-1 STUDY

EHA Library, Martin Hutchings, 214505

P53 ISOFORM D133P53A: A NEW TRANSCRIPTIONAL ENHANCER OF T-CELL EFFECTOR FUNCTION

EHA Library, Kevin Legscha, 214516

LONG-TERM SAFETY AND EFFICACY OF RITUXIMAB IN 248 ADULT IMMUNE THROMBOCYTOPENIA PATIENTS: RESULTS WITH MORE THAN 5 YEARS OF FOLLOW-UP FROM A FRENCH PROSPECTIVE REGISTRY ITP-RITUX

EHA Library, Samuel DESHAYES, 214518

THE IMPACT OF RECIPIENT AGE ON ALLOGENEIC STEM CELL TRANSPLANTATION OUTCOME –A COMPARISON BETWEEN SIBLINGS VERSUS UNRELATED VERSUS ALTERNATIVE DONORS: AN ANALYSIS ON BEHALF OF THE ALWP OF THE EBMT

EHA Library, Roni Shouval, 214596

A RANDOMISED EVALUATION OF LOW-DOSE ARA-C PLUS TOSEDOSTAT VERSUS LOW DOSE ARA-C IN OLDER PATIENTS WITH ACUTE MYELOID LEUKAEMIA: RESULTS OF THE LI-1 TRIAL

EHA Library, Mike Dennis, 214439

LONG TERM SURVIVAL OF PATIENTS WITH EVANS SYNDROME: A POPULATION-BASED COHORT STUDY

EHA Library, Dennis Lund Hansen, 214601

TWO YEARS RITUXIMAB MAINTENANCE VS. OBSERVATION AFTER FIRST LINE TREATMENT WITH BENDAMUSTINE PLUS RITUXIMAB IN PATIENTS WITH MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF THE STIL NHL7-2008 MAINTAIN TRIAL

EHA Library, Mathias Rummel, 214436

FOSTAMATINIB, A SPLEEN TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA: PRELIMINARY RESULTS OF THE SOAR PHASE 2, MULTICENTER, OPEN-LABEL STUDY

EHA Library, David J Kuter, 214446

RESULTS OF PIVOTAL PHASE 2 TRIAL OF SL-401 IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

EHA Library, Naveen Pemmaraju, 214438

PATIENTS WITH HIGH RISK FEATURES ACCORDING TO PRIMA PI HAVE SIGNIFICANTLY HIGHER RISK TO DIE EVEN IF THEY ARE LATE PROGRESSORS.

EHA Library, Marek Trneny, 214435